A new study published in Nature on Oct 30 unveiled artificial receptors that can target and fight different types of coronaviruses by designing them like building blocks, offering a new way to develop ...
Ralph Schlosstein, chairman emeritus at Evercore, examines how the corporate world has prepared for a second Donald Trump administration and offers his outlook for M&A. CNBC's MacKenzie Sigalos joins ...